Skip to main content

Advertisement

Log in

Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Unconjugated bilirubin (UCB) is the major degradation product of the heme catabolism. A growing body of evidences suggests that UCB plays major biological effects by inhibiting cell proliferation in cancer cell lines and eliciting cell toxicity particularly in neurons and glial cells. Early molecular events responsible for bilirubin-induced cytotoxicity remain poorly understood. Using HeLa cells and mouse embryonic fibroblasts, we found that UCB at a concentration of free pigment (Bf) of 80 nM induced oxidative stress, promoting a significant increase in intracellular reactive oxygen species (ROS) and a decreased cell survival (by the MTT test). The ROS increase activated the antioxidant cell response through APE1/Ref-1, a master redox regulator in eukaryotic cells. Activation of APE1/Ref-1 was followed by a concomitant activation of Egr-1 transcription factor and by an upregulation of PTEN tumor suppressor, an Egr-1 target gene, leading to inhibition of cell growth. Blocking ROS generation with N-acetylcysteine pretreatment, restored cell survival, limited the upregulation of PTEN in response to UCB, and prevented the inhibition of cell proliferation. HeLa cells transfected with mutants of the PTEN promoter or silenced with APE1/Ref-1 small interference RNA confirmed that UCB modulates a signaling pathway involving APE1/Ref-1, Egr-1, and PTEN. These findings describe a new molecular pathway involved in the cytotoxic effects of UCB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

AP-1:

activator protein-1

APE1/Ref-1:

apurinic apyrimidinic endonuclease/redox effector factor-1

Egr-1:

early growth response protein-1

H2DCFDA:

2,7-dichlorofluorescein diacetate

HSA:

human serum albumin

MEF:

mouse embryonic fibroblasts

Mrp1:

multidrug resistance-associated protein 1

MTT:

3(4,5-dimethylthiazolyl-2)-2,5 diphenyl tetrazolium

NAC:

N-acetyl-cysteine

NF-κB:

nuclear factor-κB

PTEN:

protein phosphatase and tensin homolog

ROS:

reactive oxygen species

siRNA:

small interference RNA

UCB:

unconjugated bilirubin

Bf:

free unconjugated bilirubin

References

  1. Ostrow JE, Tiribelli C (2003) Bilirubin, a curse and a boon. Gut 52:1668–1670

    Article  PubMed  CAS  Google Scholar 

  2. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046

    Article  PubMed  CAS  Google Scholar 

  3. Rigato I, Ostrow JD, Tiribelli C (2005) Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med 11:277–283

    Article  PubMed  CAS  Google Scholar 

  4. Gourley GR (1997) Bilirubin metabolism and kernicterus. Adv Pediatr 44:173–229

    PubMed  CAS  Google Scholar 

  5. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM (2006) Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117:474–485

    Article  PubMed  Google Scholar 

  6. Ahlfors CE (2001) Bilirubin-albumin binding and free bilirubin. J Perinatol 21(Suppl 1):S40–S42

    PubMed  Google Scholar 

  7. Ostrow JD, Pascolo L, Brites D, Tiribelli C (2004) Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med 10:65–70

    Article  PubMed  CAS  Google Scholar 

  8. Ostrow JD, Pascolo L, Tiribelli C (2003) Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 54:926

    Article  PubMed  Google Scholar 

  9. Dorè S, Snyder SH (1999) Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 890:167–172

    Article  PubMed  Google Scholar 

  10. Gennuso F, Fernetti C, Tirolo C, Testa N, LEpiscopo F, Caniglia S, Morale MC, Ostrow JD, Pascolo L, Tiribelli C, Marchetti B (2004) Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc Natl Acad Sci U S A 101:2470–2475

    Article  PubMed  CAS  Google Scholar 

  11. Calligaris S, Cekic D, Roca-Burgos L, Gerin F, Mazzone G, Ostrow JD, Tiribelli C (2006) Multidrug resistance associated protein 1 protects against bilirubin-induced cytotoxicity. FEBS Lett 580:1355–1359

    Article  PubMed  CAS  Google Scholar 

  12. Keshavan P, Schwemberger SJ, Smith DL, Babcock GF, Zucker SD (2004) Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer 112:433–445

    Article  PubMed  CAS  Google Scholar 

  13. Vitek L, Schwertner HA (2007) The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 3:1–57

    Article  CAS  Google Scholar 

  14. Zucker SD, Horn PS, Sherman KE (2004) Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 40:827–835

    PubMed  CAS  Google Scholar 

  15. Rodrigues CM, Sola S, Brites D (2002) Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 35:1186–1195

    Article  PubMed  CAS  Google Scholar 

  16. Oakes GH, Bend JR (2005) Early steps in bilirubin-mediated apoptosis in murine hepatoma (Hepa 1c1c7) cells are characterized by aryl hydrocarbon receptor-independent oxidative stress and activation of the mitochondrial pathway. J Biochem Mol Toxicol 19:244–255

    Article  PubMed  CAS  Google Scholar 

  17. Tell G, Damante G, Caldwell D, Kelley MR (2005) The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 7:367–384

    Article  PubMed  CAS  Google Scholar 

  18. Xanthoudakis S, Curran T (1992) Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11:653–665

    PubMed  CAS  Google Scholar 

  19. Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T (1992) Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11:3323–3335

    PubMed  CAS  Google Scholar 

  20. Huang RP, Wu JX, Fan Y, Adamson ED (1996) UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 133:211–220

    Article  PubMed  CAS  Google Scholar 

  21. Liu C, Rangnekar VM, Adamson E, Mercola D (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 5:3–28

    PubMed  CAS  Google Scholar 

  22. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72:102–109

    Article  PubMed  CAS  Google Scholar 

  23. Krones-Herzig A, Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson ED, Mercola D (2005) Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 65:5133–5143

    Article  PubMed  CAS  Google Scholar 

  24. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle I (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling. Nat Cell Biol 3:1124–1128

    Article  PubMed  CAS  Google Scholar 

  25. Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954–2963

    Article  PubMed  CAS  Google Scholar 

  26. Pines A, Bivi N, Romanello M, Damante G, Kelley MR, Adamson ED, DAndrea P, Quadrifoglio F, Moro L, Tell G (2005) Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop. Free Radic Res 39:269–281

    Article  PubMed  CAS  Google Scholar 

  27. McDonagh AF, Assisi F (1972) The ready isomerization of bilirubin-IXα in aqueous solution. Biochem J 129:797–800

    PubMed  CAS  Google Scholar 

  28. Ostrow JD, Mukerjee P (2007) Solvent partition of 14C-unconjugated bilirubin to remove labeled polar impurities. Transl Res 149:37–45

    Article  PubMed  CAS  Google Scholar 

  29. Bayón JE, Pascolo L, Gonzalo-Orden JM, Altonaga JR, Gonzalez-Gallego J, Webster CC, Haigh WG, Stelzner M, Pekow C, Tiribelli C, Ostrow JD (2001) Pitfalls in preparation of (3)H-unconjugated bilirubin by biosynthetic labeling from precursor (3)H-5-aminolevulinic acid in the dog. J Lab Clin Med 138:313–321

    Article  PubMed  Google Scholar 

  30. Hertzog PJ (2001) Isolation of embryonic fibroblasts and their use in the in vitro characterization of gene function. Methods Mol Biol 158:205–215

    PubMed  CAS  Google Scholar 

  31. Freshney RI (1994) Culture of animal cells. A manual of basic technique, 3rd edn. Wiley-Liss Inc., New York

    Google Scholar 

  32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85

    Article  PubMed  CAS  Google Scholar 

  33. Roca-Burgos L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, Ostrow JD, Tiribelli C (2006) Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res 60:724–728

    Article  CAS  Google Scholar 

  34. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271–277

    Article  PubMed  CAS  Google Scholar 

  35. Frenkel K, Gleichauf C (1991) Hydrogen peroxide formation by cells treated with a tumor promoter. Free Radic Res Commun 2:783–794

    Article  Google Scholar 

  36. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gulisano M, Kelley MR, Quadrifoglio F, Tell G (2005) Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33:4379–4394

    Article  PubMed  CAS  Google Scholar 

  37. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  PubMed  CAS  Google Scholar 

  38. Bours V, Burd PR, Brown K, Villalobos J, Park S, Ryseck RP, Bravo R, Kelly K, Siebenlist U (1992) A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol 12:685–695

    PubMed  CAS  Google Scholar 

  39. Mittal V (2004) Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5:355–365

    Article  PubMed  CAS  Google Scholar 

  40. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4:609–615

    Article  PubMed  CAS  Google Scholar 

  41. Tell G, Pines A, Arturi F, Cesaratto L, Adamson E, Puppin C, Presta I, Russo D, Filetti S, Damante G (2004) Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells. Endocrinology 145:4660–4666

    Article  PubMed  CAS  Google Scholar 

  42. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39–51

    Article  PubMed  CAS  Google Scholar 

  43. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D (1995) Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85:532–540

    PubMed  CAS  Google Scholar 

  44. Huang RP, Adamson ED (1993) Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol 12:265–273

    Article  PubMed  CAS  Google Scholar 

  45. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K (2006) Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 13:730–737

    Article  PubMed  CAS  Google Scholar 

  46. Gaiddon C, Moorthy NC, Prives C (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J 18:5609–5621

    Article  PubMed  CAS  Google Scholar 

  47. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW (2001) Regulation of PTEN transcription by p53. Mol Cell 8:317–325

    Article  PubMed  CAS  Google Scholar 

  48. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH (2001) Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11:764–768

    Article  PubMed  CAS  Google Scholar 

  49. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM (2004) Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 279:4285–4291

    Article  PubMed  CAS  Google Scholar 

  50. Whelan JT, Forbes SL, Bertrand FE (2007) CBF-1 (RBP-Jkappa) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle 6:80–84

    PubMed  CAS  Google Scholar 

  51. Robertson KA, Hill DP, Xu Y, Liu L, Van Epps S, Hockenbery DM, Park JR, Wilson TM, Kelley MR (1997) Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 8:443–449

    PubMed  CAS  Google Scholar 

  52. Fung H, Demple B (2005) A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 17:463–470

    Article  PubMed  CAS  Google Scholar 

  53. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S (2003) Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J 22:6299–6309

    Article  PubMed  CAS  Google Scholar 

  54. Finkel T (2003) Oxidant signals and oxidative stress. Curr Opin Cell Biol 15:247–254

    Article  PubMed  CAS  Google Scholar 

  55. Izumi T, Brown DB, Naidu CV, Bhakat KK, Macinnes MA, Saito H, Chen DJ, Mitra S (2005) Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci U S A 102:5739–5743

    Article  PubMed  CAS  Google Scholar 

  56. Ramana CV, Boldogh I, Izumi T, Mitra S (1998) Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci U S A 95:5061–5066

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The financial support of Telethon–Italy (grant GGP 05062) of MiUR (PRIN 2005 to GT, CT and FQ) and of Fondo Studi Fegato (Grant to CT) is gratefully acknowledged. SC was supported by a PhD fellowship by Ministero Affari Esteri, Rome, Italy. The authors wish to thank E. Adamson for the PTEN promoter plasmids.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianluca Tell.

Additional information

L. Cesaratto and S. D. Calligaris contributed equally to the present work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cesaratto, L., Calligaris, S.D., Vascotto, C. et al. Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway. J Mol Med 85, 1099–1112 (2007). https://doi.org/10.1007/s00109-007-0204-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-007-0204-3

Keywords

Navigation